Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Shuren At FDLI: Least-Burdensome, Real-World Evidence Efforts Picking Up

May 10 2017

• By Elizabeth Orr

Related Content

A New NEST: MDIC Leaders Discuss Relocation, National Evaluation System And More

Apr 27 2017

Single Marketing Application Review For Multiple Jurisdictions On Horizon

Apr 06 2017

23andMe Opens Up FDA Pathway For DTC Genetic Predisposition Tests

Apr 06 2017

FDA 510(k)-Exempts 72 Devices, Mostly Diagnostics

Apr 12 2017

US FDA Warning Letter Scrutinizes Abbott Over Cybersecurity, Battery Lapses

Apr 13 2017

US FDA Could Be Mostly Spared From Trump's Regulation-Slashing Order

Feb 13 2017

More Manufacturers Sign Up For Single Audits As MDSAP Becomes Operational

Feb 16 2017

MDIC Project Looks To New P-Value Possibilities

Oct 21 2016

Pilot Of New US Evaluation System Will Include At Least Two Devices

Oct 31 2016

Shuren To Industry: 'Hire A Hacker'

May 17 2016

Related Companies

23andMe, Inc.

Abbott

Additional Topics

United States Regulation FDA Medical Device

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About

About UsOpens in new window
Meet the Team
AdvertiseOpens in new window
Contact Us

Account

My Account
My View
Email Preferences
Start Free TrialOpens in new window

Publications

Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window